A Multi-Dose Study With a Treatment for Open-Angle Glaucoma

Alcon Research

Overview

The purpose of this study is to determine whether Anecortave Acetate is effective for lowering intraocular pressure caused by open-angle glaucoma.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Conditions

Open-Angle Glaucoma

Interventions

Anecortave AcetateDRUG

Low dose Sustained release depot suspension

Anecortave AcetateDRUG

Middle dose Sustained release depot suspension

Anecortave AcetateDRUG

High dose Sustained release depot suspension

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients at least 18 years old with a clinical diagnosis of Open-Angle Glaucoma for at least 6 months and currently treated with a monotherapy hypotensive medication Exclusion Criteria: * Prior angle surgery in the study eye, severe visual field loss in either eye, and any other form of glaucoma besides open-angle glaucoma

Outcomes

Primary Outcomes

Mean Intraocular Pressure

Time frame: 6 months

Secondary Outcomes

Percent of patients with therapeutic benefit, number and percent of treatment failure and time to treatment failure

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.